申请人:Affectis Pharmaceuticals AG
公开号:EP2386541A1
公开(公告)日:2011-11-16
Disclosed are novel methods for the synthesis of N-substituted indol-3-yl-alkylamide compounds which act as P2X7R antagonists, said methods involving the rearrangement of an oxime intermediate.
本发明揭示了一种合成N-取代的吲哚-3-基-烷基酰胺化合物的新方法,该化合物作为P2X7R拮抗剂,所述方法涉及氧肟中间体的重排。